Future of Antiarrhythmic Drugs: Essential Roles in 2025 and Beyond (Joint Session)

Description

This session will include a series of presentations highlighting important yet often underrecognized aspects of contemporary use of antiarrhythmic drugs. These agents a still a critical aspect of patient care, even with the advances in catheter-based therapy. A joint session with EHRA.

Learning Objectives

Gain knowledge about the current needs and updated classification of antiarrhythmic drugs, including the "ABC" acronym, and explore upcoming innovations and developments in antiarrhythmic therapy.
Learn to identify the most frequent proarrhythmia and toxic adverse events associated with antiarrhythmic drugs, and acquire strategies for their prevention and treatment.
Assess the interactions of antiarrhythmic drugs with patient subpopulations, other medications, and cardiac implantable electronic devices (CIEDs)

Session Chair(s)

Jose Merino, MD, PhD
Zachary Goldberger, MD

Presentation

The ABCs of AADs: Current Necessities and Updated Classifications
Presenter(s): Kristen B. Campbell, PharmD

Antiarrhythmics in Special Populations
Presenter(s): Dobromir Dobrev, MD

Controversies in Antiarrhythmic Therapy
Presenter(s): Megan Labreck, PharmD

Innovations in Antiarrhythmic Therapy
Presenter(s): Dan M. Roden, MD

When Antiarrhythmic Drugs Do Not Work in Isolation: What is the Best Combination?
Presenter(s): Win-Kuang Shen, MD

Disclosures

Kristen Campbell:

Nothing Relevant to Disclose

Dobromir Dobrev:

Nothing Relevant to Disclose

Megan Labreck:

AtriCure, Inc. (content development - learning modules - Consulting)
Boston Scientific (Honoraria/Speaking/Consulting Fee - Speaking and Teaching)

Dan Roden:

Nothing Relevant to Disclose

Win-Kuang Shen:

Nothing Relevant to Disclose

To view all Heart Rhythm 2025 Faculty Disclosures, please click here.

Education Framework

General Concepts
   --   Pathophysiological Basis of Cardiac Arrhythmias and Basic EP
      --   4. Know abnormalities of cardiac electrophysiology, including altered ion channel function (inherited and drug-induced) and their effect on action potentials.

General Concepts
   --   Pathophysiological Basis of Cardiac Arrhythmias and Basic EP
      --   6. Know the mechanisms of cardiac arrhythmias including re-entry, triggered activity, and abnormal automaticity, as well as associated triggers such as ischemia, changes in autonomic tone, and drugs.

Summary

Availability:

No future session

Cost:

FREE

Credit Offered:

No Credit Offered